drugset / Trial / NCT04027348
Palliative Management of Inoperable Malignant Bowel Obstruction
NaSingle-groupOpen-labelTreatment
Summary
To identify the role of palliative medical management of inoperable malignant bowel obstruction (MBO) with Octreotide, Dexamethasone and Metoclopramide given together as triple therapy.
Timeline
- Start
- 2019-06-26
- Primary completion
- 2021-09-03
- Completion
- 2021-09-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexamethasone | Small molecule | 4 mg | Intravenous |
| Subject | Metoclopramide | Small molecule | 10 mg | Intravenous |
| Subject | Octreotide | Peptide | 300 ug | Intravenous |